scholarly journals Does Testosterone Administration Increase Competitiveness, Confidence and Financial Risk-taking in Men?

2021 ◽  
Author(s):  
Amos Nadler ◽  
Matthias Wibral ◽  
Thomas Dohmen ◽  
Armin Falk ◽  
Alessandro Previtero ◽  
...  

The sex steroid hormone testosterone regulates male-typical behaviors such as aggression and displays of dominance in non-human animals. According to the Challenge Hypothesis, these effects arise from context-sensitive testosterone increases that facilitate inter-male competitions over resources, status, and mates. A growing literature documents similar effects of testosterone on economic behaviors related to competition and risk-taking in humans, though findings to date have been mixed. Here, we report two randomized double-blind placebo-controlled testosterone administration experiments, whose combined sample (N = 334) is substantially larger than any previous investigation of the topic (N1 = 91, N2 = 243). The studies were designed independently by research groups in Europe and the US, and both investigated testosterone’s effects on men’s willingness to compete, confidence, and risk-taking—dimensions of economic behavior that are theoretically linked to the Challenge Hypothesis, show robust sex differences, and predict important real-life outcomes such as career choice. We find no evidence for effects of testosterone on any of the behavioral tasks studied across the two experiments, with effect point estimates that are small and inconsistent. The studies had 90% statistical power to detect effects that are larger than d = 0.68 and d = 0.42 respectively, and equivalence tests confidently reject effects that are greater than these magnitudes. Our findings cast doubt on the proposition that testosterone is a meaningful causal driver of the stereotypically “masculine” dimensions of economic behavior studied, and suggest that even if true effects existed, detecting them experimentally would be challenging.

2020 ◽  
Author(s):  
Tobias Baer ◽  
Simone Schnall

Making decisions over extended periods of time is cognitively taxing and can lead to decision fatigue, which is linked to a preference for the ‘default’ option, namely whatever decision involves the least cognitive effort. Such effects have been demonstrated across a number of applied settings, including forensic and clinical contexts. An open question, however, is whether this necessarily leads to worse decision outcomes. Using 26,501 credit restructuring applications evaluated by credit officers of a major bank, here we show that in this real-life financial risk taking context credit loan approvals across the course of a day decreased during midday compared to early or later in the workday, reflecting a preference for the default option. We then modeled the bank’s additional credit collection if all decisions had been made during early morning levels of approval. This would have resulted in $509,023 extra revenue for the bank, for one month. Thus, we provide further evidence for decision-fatigue, and that it can have a substantial negative impact in the finance sector that warrants considerations to counteract it.


2021 ◽  
Author(s):  
Mikhail Votinov ◽  
Irina S Knyazeva ◽  
Ute Habel ◽  
Kerstin Konrad ◽  
Andrei A. Puiu

We investigated the effects of testosterone administration on aspects of decision-making within the Prospect Theory framework. Using bayesian modeling, we assessed risk-taking under framing and Endowment Effect (effect of possession). We administered 100mg testosterone to forty men in a double-blind placebo-controlled fully-randomized cross-over experiment where they participated in two tasks. One was a risktaking task with binary choices under positive and negative framing with different probabilities. In a second task, participants had to bid for for two categories of items, hedonic and utilitarian. We observed a significant increase in serum testosterone concentrations after transdermal application. Compared to placebo, testosterone administration increased risk-taking under the positive framing and decreased under the negative framing. The sensitivity to gain was positive in each framing. Our model showed that decision-making is jointly influenced by testosterone and the trade-off between gains and losses. Moreover, while the endowment effect was more pronounced for hedonic than for utilitarian items, the effect was independent of testosterone. The findings provide novel information for the complex modulatory role of testosterone on risk-taking. The proposed models of effects of individual differences in testosterone on risk-taking could be used as predictive models.


2013 ◽  
Author(s):  
Rod Duclos ◽  
Echo Wen Wan ◽  
Yuwei Jiang

2021 ◽  
pp. 1-8
Author(s):  
Norin Ahmed ◽  
Jessica K. Bone ◽  
Gemma Lewis ◽  
Nick Freemantle ◽  
Catherine J. Harmer ◽  
...  

Abstract Background According to the cognitive neuropsychological model, antidepressants reduce symptoms of depression and anxiety by increasing positive relative to negative information processing. Most studies of whether antidepressants alter emotional processing use small samples of healthy individuals, which lead to low statistical power and selection bias and are difficult to generalise to clinical practice. We tested whether the selective serotonin reuptake inhibitor (SSRI) sertraline altered recall of positive and negative information in a large randomised controlled trial (RCT) of patients with depressive symptoms recruited from primary care. Methods The PANDA trial was a pragmatic multicentre double-blind RCT comparing sertraline with placebo. Memory for personality descriptors was tested at baseline and 2 and 6 weeks after randomisation using a computerised emotional categorisation task followed by a free recall. We measured the number of positive and negative words correctly recalled (hits). Poisson mixed models were used to analyse longitudinal associations between treatment allocation and hits. Results A total of 576 participants (88% of those randomised) completed the recall task at 2 and 6 weeks. We found no evidence that positive or negative hits differed according to treatment allocation at 2 or 6 weeks (adjusted positive hits ratio = 0.97, 95% CI 0.90–1.05, p = 0.52; adjusted negative hits ratio = 0.99, 95% CI 0.90–1.08, p = 0.76). Conclusions In the largest individual placebo-controlled trial of an antidepressant not funded by the pharmaceutical industry, we found no evidence that sertraline altered positive or negative recall early in treatment. These findings challenge some assumptions of the cognitive neuropsychological model of antidepressant action.


Sign in / Sign up

Export Citation Format

Share Document